The global Serotonin Norepinephrine Inhibitor market is estimated to be valued at US$ 6.29 billion in 2022 and is expected to exhibit a CAGR of 3.8% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.Market Overview:Serotonin Norepinephrine Inhibitors are a class of drugs used to treat mood disorders, including depression and anxiety. They...
0 Commentarios
0 Acciones
1558 Views
0 Vista previa
The Serotonin Norepinephrine Inhibitor Market is estimated to be valued at US$ 6.53 Bn in 2023 and is expected to exhibit a CAGR of 3.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Serotonin norepinephrine inhibitors (SNRIs) are a class of antidepressant medications that function through influencing levels of...
0 Commentarios
0 Acciones
1178 Views
0 Vista previa